Today's Margaret Hamburg news...
- While the FDA commissioner nominee requires senate confirmation, the deputy commissioner does not. Therefore, deputy Sharfstein will be the acting head of FDA.
- The RPM Report makes some informed statements based on Elsevier's (not free) Pink Sheets, and suggests that the Hamburg-Sharfstein duality will be a confirmation issue and an agency challenge for Hamburg. Apparently, the Obama administration is denying an plans to split the agency.
- Kiplinger says Hamburg "is expected" to be confirmed easily, and that there will be a lot of policy changes made quickly afterwards.
No comments:
Post a Comment